Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology now and into the future.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives, while creating value for society. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.
Twitter Feed
-
We’re proud to support World Parkinson’s Day joining people living with Parkinson's, supporters, fundraisers and families, carers and clinicians, to come together and tell their story. To find out more about our work and latest research, visit https:/
— UCB News (@ucb_news) 11.04.2021 -
Introducing #ImmunologySummit2021, an immersive digital experience focussing on driving change. Register your interest for the event TODAY! Be sure to select a topic of interest in the drop down.
— UCB News (@ucb_news) 08.04.2021 -
On this year's #WorldHealthDay, UCB is committed to combating the unmet needs of women living with chronic inflammatory diseases. To learn more about these conditions, visit https://t.co/33gbJ56QXW to check out the resources available as part of the #
— UCB News (@ucb_news) 07.04.2021
Instagram Feed
At UCB, we take our responsibility
to the planet very seriously.
UCB Ventures, our strategic corporate venture fund established in 2017
